sulconazole has been researched along with Onychomycosis in 1 studies
sulconazole: RN given refers to cpd with unspecified isomeric designation; structure given in first source
sulconazole : A racemate comprising equimolar amounts of (R)- and (S)-sulconazole. An antifungal agent with activity against Candida species, it is used (generally as the nitrate salt) for the topical treatment of fungal skin infections.
1-{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole : A member of the class of imidazoles that is 1-ethyl-1H-imidazole in which one of the hydrogens of the methyl group is replaced by a (4-chlorobenzyl)sulfanediyl group while a second is replaced by a 2,4-dichlorophenyl group.
Onychomycosis: A fungal infection of the nail, usually caused by DERMATOPHYTES; YEASTS; or nondermatophyte MOLDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Its antifungal activity has been compared to ciclopiroxolamine and sulconazole, commonly used in onychomycosis treatment and chosen because of their very different chemical structures." | 7.70 | Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis. ( Chaumont, JP; Michel, L; Millet-Clerc, J; Yang, D, 1999) |
| " Its antifungal activity has been compared to ciclopiroxolamine and sulconazole, commonly used in onychomycosis treatment and chosen because of their very different chemical structures." | 3.70 | Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis. ( Chaumont, JP; Michel, L; Millet-Clerc, J; Yang, D, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, D | 1 |
| Michel, L | 1 |
| Chaumont, JP | 1 |
| Millet-Clerc, J | 1 |
1 other study available for sulconazole and Onychomycosis
| Article | Year |
|---|---|
Use of caryophyllene oxide as an antifungal agent in an in vitro experimental model of onychomycosis.
Topics: Animals; Antifungal Agents; Ciclopirox; Hoof and Claw; Humans; Imidazoles; Onychomycosis; Polycyclic | 1999 |